ALB and neoplasm: Prognosis is not determined by stage alone, but by the interplay of tumor-related (tumor burden, head and neck localization, perineural invasion, metastatic pattern), host-related (age, ECOG performance status, immunosuppression, comorbidities) and inflammatory or nutritional markers (e.g., LDH, NLR, albumin, BMI).